PPARA and metabolic dysfunction-associated steatotic liver disease: It has also been reported that butyrate is able to upregulate hepatic expression of PPAR-α, an essential regulator for mitochondrial fatty acid oxidation, alleviating HFD-induced NAFLD in rats (Sun et al., 2018).